StockDrifts LogoStockDrifts

Stella Pharma Corporation 4888

Company
ステラファーマ株式会社Stella Pharma Corporation
Investors
6
Buys
14
Total Value
¥20.2B ($130.4M)
Avg Return
+66.21%
Last Filing
2026-04-27

Stella Pharma Corporation (4888) has 14 disclosed large-shareholding filings and 17 disclosed disposals on record, filed by 6 distinct investors. Together those filings cover ¥20.2B ($130.4M) in reported transaction value. The earliest filing StockDrifts holds for Stella Pharma Corporation is dated 2021-04-26; the most recent is 2026-04-27. All of it is parsed from EDINET large-shareholding (5%+) reports, the official disclosure system operated by the Financial Services Agency (Japan). Across these filings the average return since disclosure is +66.21%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent filings

DateTypeSourceInsiderPurposeSharesPrice at filingReturnValue
2026-07-01BUYMarket Buy
ハイツ・キャピタル・マネジメント・インク(Heights Capital Management, Inc.)
Heights Capital Management, Inc.
passive2.1M¥307+0.0%¥290M ($1.9M)
2026-06-29BUYMarket Buy
ハイツ・キャピタル・マネジメント・インク(Heights Capital Management, Inc.)
Heights Capital Management, Inc.
passive3.1M¥310+4.2%¥961M ($6.2M)
2026-06-29BUYMarket Buy
ハイツ・キャピタル・マネジメント・インク(Heights Capital Management, Inc.)
Heights Capital Management, Inc.
passive3.1M¥310+4.2%¥961M ($6.2M)
2026-04-27BUYsubscription
ハイツ・キャピタル・マネジメント・インク(Heights Capital Management, Inc.)
Heights Capital Management, Inc.
passive1.1M¥540-15.0%¥524M ($3.4M)
2026-04-23BUYsubscription
ハイツ・キャピタル・マネジメント・インク(Heights Capital Management, Inc.)
Heights Capital Management, Inc.
passive2.0M¥543-15.5%¥1.1B ($7.2M)
2025-11-20BUYunknown
アモーヴァ・アセットマネジメント株式会社
Amova Asset Management Co., Ltd.
other65.5K¥254+181.9%¥1.2B ($7.5M)
2025-09-19BUYMarket Buy
アモーヴァ・アセットマネジメント株式会社
Amova Asset Management Co., Ltd.
other2.0M¥350+104.6%¥17M ($108K)
2025-05-08SELLunknown
日興アセットマネジメント株式会社
Nikko Asset Management Co.,Ltd.
other1.9M¥327-119.0%¥224M ($1.4M)
2025-03-21SELLunknown
日興アセットマネジメント株式会社
Nikko Asset Management Co.,Ltd.
other2.6M¥410-74.6%¥322M ($2.1M)
2024-07-05SELLsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other1.5M¥410-74.6%¥176M ($1.1M)
2024-06-21SELLsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other2.0M¥370-93.5%¥210M ($1.4M)
2024-06-07SELLsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other2.6M¥357-100.6%¥193M ($1.2M)
2023-08-22SELLsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other3.2M¥318-125.2%¥100M ($644K)
2023-06-22SELLsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other3.5M¥323-121.7%¥99M ($637K)
2023-05-22SELLsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other3.9M¥347-106.3%¥106M ($684K)
2023-04-12SELLsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other4.2M¥374-91.4%¥113M ($730K)
2023-03-08BUYsubscription
株式会社 三井住友銀行
Sumitomo Mitsui Banking Corporation
other13.4K¥411+74.2%¥582M ($3.8M)
2023-03-08BUYsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other4.6M¥411+74.2%¥1.6B ($10.4M)
2023-02-14BUYsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other4.8M¥404+77.2%¥1.7B ($10.7M)
2023-02-14BUYsubscription
株式会社 三井住友銀行
Sumitomo Mitsui Banking Corporation
other45.6K¥404+77.2%¥18M ($119K)
2023-01-17SELLsubscription
株式会社 三井住友銀行
Sumitomo Mitsui Banking Corporation
other45.6K¥356-101.1%¥5M ($33K)
2023-01-17BUYsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other5.2M¥356+101.1%¥1.6B ($10.1M)
2023-01-11BUYsubscription
株式会社 三井住友銀行
Sumitomo Mitsui Banking Corporation
other60.6K¥386+85.5%¥23M ($151K)
2023-01-11BUYsubscription
SMBC日興証券株式会社
SMBC Nikko Securities Inc.
other5.5M¥386+85.5%¥2.1B ($13.6M)
2023-01-10BUYMarket Buy
日興アセットマネジメント株式会社
Nikko Asset Management Co.,Ltd.
other2.8M¥379+88.9%¥203M ($1.3M)
2022-05-25SELLMarket Buy
株式会社INCJ
INCJ, Ltd.
passive1.0M¥434-65.0%¥495M ($3.2M)
2022-03-15SELLunknown
ステラケミファ株式会社
STELLA CHEMIFA CORPORATION
activist11.4M¥599-19.5%¥1.1B ($7.1M)
2022-03-15BUYunknown
ステラケミファ株式会社
STELLA CHEMIFA CORPORATION
activist11.4M¥599+19.5%¥1.1B ($7.1M)
2022-02-09SELLMarket Buy
株式会社INCJ
INCJ, Ltd.
passive2.2M¥647-10.7%¥206M ($1.3M)
2022-01-27SELLMarket Buy
株式会社INCJ
INCJ, Ltd.
passive2.5M¥621-15.3%¥224M ($1.4M)
2022-01-13SELLMarket Buy
株式会社INCJ
INCJ, Ltd.
passive2.9M¥913+21.6%¥374M ($2.4M)
2021-10-21BUYMarket Buy
日興アセットマネジメント株式会社
Nikko Asset Management Co.,Ltd.
other2.3M¥557+28.6%¥230M ($1.5M)
2021-10-06BUYunknown
日興アセットマネジメント株式会社
Nikko Asset Management Co.,Ltd.
other1.9M¥660+8.5%¥1.2B ($8.1M)
2021-06-25SELLMarket Buy
株式会社INCJ
INCJ, Ltd.
passive3.3M¥586-22.2%¥250M ($1.6M)
2021-05-06SELLMarket Buy
株式会社INCJ
INCJ, Ltd.
passive3.6M¥571-25.4%¥2.0B ($12.7M)
2021-04-30BUYMarket Buy
株式会社INCJ
INCJ, Ltd.
passive7.0M¥555+29.0%¥3.9B ($25.1M)
2021-04-26BUYunknown
ステラケミファ株式会社
STELLA CHEMIFA CORPORATION
strategic12.8M¥636+12.6%¥8.1B ($52.4M)
2021-04-26BUYunknown
ステラケミファ株式会社
STELLA CHEMIFA CORPORATION
strategic12.8M¥636+12.6%¥8.1B ($52.4M)

Frequently asked questions

Who has been buying Stella Pharma Corporation stock?
6 distinct investors have filed 14 disclosed large-shareholding filings in Stella Pharma Corporation (4888), most recently on 2026-04-27. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Stella Pharma Corporation have?
Stella Pharma Corporation has 14 buy-side and 17 sell-side disclosures on record, covering ¥20.2B ($130.4M) in total reported value, spanning 2021-04-26 to 2026-04-27.
Where does StockDrifts get Stella Pharma Corporation insider data?
From EDINET large-shareholding (5%+) reports — the official filing system run by the Financial Services Agency (Japan). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from EDINET.
Do insider buys in Japanese stocks predict returns?
Not uniformly. StockDrifts scored 101,000+ Japanese large-shareholding filings on fixed 12-month forward returns and found the predictive power concentrated in specific filer types and filing patterns rather than spread evenly across all disclosures.

Source filings

Every trade listed above is disclosed in EDINET large-shareholding (5%+) reports, filed with the Financial Services Agency (Japan). View the original EDINET filings for Stella Pharma Corporation. For how StockDrifts scores these disclosures, see the Japan insider signal tier research, or browse every Japanese stock we track.